Resources

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (September 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

Presentations from the 2019 MS Summit

View Presentations here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (June 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (April 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

MS Coalition Brochure (January 2012)

The Multiple Sclerosis Coalition (MSC) was founded in 2005 by three independent multiple sclerosis (MS) organizations in an effort to work together to benefit individuals with MS. Since that time, the MSC has grown to nine member organizations, all of whom provide critical MS programs and services.    Download here

Follow us on Twitter

TwitterFollow

MS Coalition
Retweet on TwitterMS Coalition Retweeted
MSassociationMS Assoc. of America@MSassociation·
31 Mar

Having a chronic illness can be tough. Explaining your diagnosis to others can be difficult, too. See what members of @MS_HealthUnion's community had to say about it on #MSConversations: https://blog.mymsaa.org/community-views-strangest-comments/

Reply on Twitter 1377307210959687683Retweet on Twitter 13773072109596876832Like on Twitter 13773072109596876833Twitter 1377307210959687683
Retweet on TwitterMS Coalition Retweeted
genentechGenentech@genentech·
16 Mar

Multiple sclerosis (MS) is a progressive & often debilitating disease for those who have been diagnosed. This #MSAwarenessMonth, learn more about our work in MS & how early diagnosis & treatment can help delay disease progression. #MSVisibility

Reply on Twitter 1371816018260029441Retweet on Twitter 1371816018260029441136Like on Twitter 1371816018260029441289Twitter 1371816018260029441
Retweet on TwitterMS Coalition Retweeted
iConquerMSiConquerMS@iConquerMS·
31 Mar

How does iConquerMS enable people living with #MultipleSclerosis to participate in #MS research? Visit http://www.iconquerms.org to find out.

Reply on Twitter 1377293432658481152Retweet on Twitter 13772934326584811521Like on Twitter 13772934326584811521Twitter 1377293432658481152
Load More...